Clinical Trials
35
Active:4
Completed:7
Trial Phases
3 Phases
Phase 2:15
Phase 3:9
Not Applicable:6
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (30 trials with phase data)• Click on a phase to view related trials
Phase 2
15 (50.0%)Phase 3
9 (30.0%)Not Applicable
6 (20.0%)Use of Interim PET Scan to Modify Therapy in Advanced Hodgkin's Lymphoma in Order to Improve Outcomes
Not Applicable
Completed
- Conditions
- Hodgkin's Lymphoma
- Interventions
- Drug: Escalated BEACOPP
- First Posted Date
- 2011-02-28
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- Cancer Institute WIA
- Target Recruit Count
- 50
- Registration Number
- NCT01304849
- Locations
- 🇮🇳
Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, India
News
No news found